A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Public ClinicalTrials.gov record NCT02781311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety, tolerability and efficacy of the oral administration of setipiprant tablets 1000 mg twice daily (BID) relative to placebo in 18 to 49 years old males with androgenetic alopecia (AGA).
Study identification
- NCT ID
- NCT02781311
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 169 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2016 (Actual)
- Primary completion
- Mar 15, 2018 (Actual)
- Completion
- May 22, 2018 (Actual)
- Last update posted
- Apr 5, 2019
2016 – 2018
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Petrus Center for Aesthetic Surgery & Hair Transplantation | Little Rock | Arkansas | 72205 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Radiant Research, Inc. | Santa Rosa | California | 95405 | — |
| DeNova Research | Chicago | Illinois | 60611 | — |
| Heartland Research Associates, LLC | Wichita | Kansas | 67207 | — |
| Michigan Center for Skin Care Research | Clinton Township | Michigan | 48038 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| University of Minnesota Department of Dermatology Division of Clinical research | Minneapolis | Minnesota | 55455 | — |
| Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard | Winston-Salem | North Carolina | 27157 | — |
| Cleveland Clinic, Dept of Dermatology | Cleveland | Ohio | 44195 | — |
| NW Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Penn State Hershey Medical Center Dermatology Research Office | Hershey | Pennsylvania | 17033 | — |
| Radiant Research, Inc. | Greer | South Carolina | 29650 | — |
| DermResearch, Inc | Austin | Texas | 78759 | — |
| Suzzane Bruce and Associates P.A., The Center for Skin Research | Katy | Texas | 77494 | — |
| The Education & Research Foundation, Inc | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02781311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02781311 live on ClinicalTrials.gov.